(202) 599-8435

Partner Headlines

RADARS: Opioid Abuse on the Decline

After decades of opioid abuse, a new study by the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System shows that abuse rates are decreasing. Results from the...
Posted on Jan 19, 2015
, By

Pharmacogenetic Testing in Pain Medicine: Experts Weigh in

Genetics are increasingly explaining the variability of responses to medical treatment and helping to predict more effective and safer medication choices. Pain Medicine News asked four pain...
Posted on Jan 06, 2015
, By

US Pain Foundation: Debating the Rescheduling of Hydrocodone

Cindy Steinberg of the Massachusetts Pain Initiative and the U.S. Pain Foundation participated in a Boston Globe debate about the recent hydrocodone rescheduling by the Drug Enforcement...
Posted on Dec 03, 2014
, By

FDA Approves Fourth Medication with Abuse-Deterrent Labeling

The Food and Drug Administration (FDA) announced the approval of the first hydrocodone medication with abuse-deterrent properties, the fourth medication to receive such labeling. According to its...
Posted on Nov 20, 2014
, By

NABP Launches Pharmacy Generic Top-Level Domain To Help Consumers Find Safe Pharmacies Online

The National Association of Boards of Pharmacy® (NABP®) has launched the .pharmacy generic Top-Level Domain (gTLD) to provide consumers around the world a means for identifying safe, legal, and...
Posted on Sep 29, 2014
, By

Egalet Announces Successful Meeting with FDA To Discuss Abuse Deterrence

Egalet Corporation today announced the completion of a successful end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding Egalet-002, an abuse-deterrent,...
Posted on Aug 19, 2014
, By

Stanton Recognized for Excellence in Pain Management Education

Every month, The Pain Community (TPC) recognizes a “TPC Hero” for outstanding dedication to making a difference for those living with pain. For the month of July, TPC has honored Marsha Stanton,...
Posted on Aug 13, 2014
, By